Back to Search
MARC WEBER, MD
MD
Pediatrics Physician
NPI: 1609830850IndividualAccepts Medicare
Specialties, Licenses & Credentials
Pediatrics PhysicianPrimary
Pediatrics
Code: 208000000X
28582(SC)D70060(MD)
CMS Specialties
PrimaryPEDIATRIC MEDICINE
Education
UNIVERSITY OF TENNESSEE, HSC, COLLEGE OF MEDICINE
Class of 1974
Research & Publications (20)
Treatment of patients with hypertension and arthritis pain: new concepts.
PMID 19393822·Am J Med·2009
6-review
Achieving blood pressure goals: should angiotensin II receptor blockers become first-line treatment in hypertension?
PMID 19587555·J Hypertens Suppl·2009
6-review
Using placebo in hypertension clinical trials: new information and new opportunities.
PMID 18496554·J Hum Hypertens·2008
8-other
Beta-blockers in the treatment of hypertension: new data, new directions.
PMID 18326967·J Clin Hypertens (Greenwich)·2008
8-other
Secondary analysis of the VALUE trial: intriguing new questions.
PMID 17686374·Curr Hypertens Rep·2007
8-other
New opportunities in cardiovascular patient management: a survey of clinical data on the combination of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers.
PMID 17666198·Am J Cardiol·2007
6-review
Baseline characteristics in the Avoiding Cardiovascular events through Combination therapy in Patients Living with Systolic Hypertension (ACCOMPLISH) trial: a hypertensive population at high cardiovascular risk.
PMID 17453747·Blood Press·2007
4-observational
Efficacy of a once-daily formulation of carvedilol for the treatment of hypertension.
PMID 17170609·J Clin Hypertens (Greenwich)·2006
4-observational
Upper extremity arterial combat injury management.
PMID 17060232·Perspect Vasc Surg Endovasc Ther·2006
6-review
Controlled-release carvedilol in the treatment of essential hypertension.
PMID 17023230·Am J Cardiol·2006
2-rct
Hypertension treatment and implications of recent cardiovascular outcome trials.
PMID 16601560·J Hypertens Suppl·2006
6-review
An effectiveness study comparing algorithm-based antihypertensive therapy with previous treatments using conventional and ambulatory blood pressure measurements.
PMID 16596026·J Clin Hypertens (Greenwich)·2006
3-trial
Clinical trials report. Vascular effects beyond blood pressure: the CAMELOT study.
PMID 16061038·Curr Hypertens Rep·2005
8-other
Angiotensin-II receptor blockers for hypertension and heart failure: quality of life and outcomes.
PMID 15766065·Manag Care Interface·2005
8-other
Endogenous leukemia inhibitory factor attenuates endotoxin response.
PMID 15702085·Lab Invest·2005
4-observational
Clinical trials report. Consequences of new-onset diabetes during the treatment of hypertension.
PMID 15257863·Curr Hypertens Rep·2004
8-other
Angiotensin II receptor blockers and cardiovascular outcomes: what does the future hold?
PMID 12806587·J Renin Angiotensin Aldosterone Syst·2003
6-review
Evaluation of the 24 h effects of the angiotensin II receptor blockers: means to improve cardiovascular outcomes?
PMID 14624172·Blood Press Monit·2003
6-review
The telmisartan programme of research tO show Telmisartan End-organ proteCTION (PROTECTION) programme.
PMID 14513950·J Hypertens Suppl·2003
6-review
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 18045 GEORGIA AVE
OLNEY, MD 20832 - Phone
- (888) 808-6483
Quick Facts
- NPI
- 1609830850
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 1
- Years in Practice
- 52
- Publications
- 20
Are you this provider?
Claim Your Profile